591 related articles for article (PubMed ID: 17557269)
1. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
Ahmed MS; Wong CF
J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia.
Korte MR; van Heerde MJ; de Man RA; Betjes MH
Neth J Med; 2008 Jan; 66(1):27-30. PubMed ID: 18219065
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
Laurino S; Borrelli S; Catapano F; Mascia S; D'Angio' P; Calabria M; Grimaldi M; Salvio A; Minutolo R; De Nicola L; Conte G
G Ital Nefrol; 2009; 26(3):318-27. PubMed ID: 19554529
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection and cryoglobulinaemia.
Lunel F; Musset L
Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994
[TBL] [Abstract][Full Text] [Related]
5. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha.
Zuckerman E; Keren D; Slobodin G; Rosner I; Rozenbaum M; Toubi E; Sabo E; Tsykounov I; Naschitz JE; Yeshurun D
J Rheumatol; 2000 Sep; 27(9):2172-8. PubMed ID: 10990230
[TBL] [Abstract][Full Text] [Related]
6. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
Quartuccio L; Soardo G; Romano G; Zaja F; Scott CA; De Marchi G; Fabris M; Ferraccioli G; De Vita S
Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196
[TBL] [Abstract][Full Text] [Related]
7. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches.
Fabrizi F; Lunghi G; Messa P; Martin P
J Nephrol; 2008; 21(6):813-25. PubMed ID: 19034865
[TBL] [Abstract][Full Text] [Related]
8. [A case of membranoproliferative glomerulonephritis due to type II cryoglobulinemia probably associated with hepatitis C virus infection].
Ikeda Y; Nakano H; Sakemi T; Nagano Y; Otsuka N; Baba N; Syouno Y; Yamaguchi K
Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):284-8. PubMed ID: 8196226
[TBL] [Abstract][Full Text] [Related]
9. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature.
Ferri C; Cacoub P; Mazzaro C; Roccatello D; Scaini P; Sebastiani M; Tavoni A; Zignego AL; De Vita S
Autoimmun Rev; 2011 Nov; 11(1):48-55. PubMed ID: 21821153
[TBL] [Abstract][Full Text] [Related]
10. Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients.
Basse G; Ribes D; Kamar N; Mehrenberger M; Sallusto F; Esposito L; Guitard J; Lavayssière L; Oksman F; Durand D; Rostaing L
Transplant Proc; 2006 Sep; 38(7):2308-10. PubMed ID: 16980074
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection with and without cryoglobulinemia as a case of Churg-Strauss syndrome.
Mercié P; Viallard JF; Faure I; Trimoulet P; Vital A; Lifermann F; Leng B; Pellegrin JL
J Rheumatol; 2000 Mar; 27(3):814-7. PubMed ID: 10743831
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.
Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM
Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis C virus associated cryoglobulinemia at a veterans hospital.
Kerr GS; Rofail M; Lewis JH; Kumar P; Seeff LB
J Rheumatol; 1997 Nov; 24(11):2134-8. PubMed ID: 9375872
[TBL] [Abstract][Full Text] [Related]
14. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis.
Sène D; Ghillani-Dalbin P; Amoura Z; Musset L; Cacoub P
Arthritis Rheum; 2009 Dec; 60(12):3848-55. PubMed ID: 19950292
[TBL] [Abstract][Full Text] [Related]
15. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.
Visentini M; Ludovisi S; Petrarca A; Pulvirenti F; Zaramella M; Monti M; Conti V; Ranieri J; Colantuono S; Fognani E; Piluso A; Tinelli C; Zignego AL; Mondelli MU; Fiorilli M; Casato M
Autoimmun Rev; 2011 Sep; 10(11):714-9. PubMed ID: 21570494
[TBL] [Abstract][Full Text] [Related]
16. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies.
Garini G; Allegri L; Lannuzzella F; Vaglio A; Buzio C
Acta Biomed; 2007; 78(1):51-9. PubMed ID: 17687818
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of low-dose rituximab for mixed cryoglobulinemia.
Visentini M; Granata M; Veneziano ML; Borghese F; Carlesimo M; Pimpinelli F; Fiorilli M; Casato M
Clin Immunol; 2007 Oct; 125(1):30-3. PubMed ID: 17692572
[TBL] [Abstract][Full Text] [Related]
18. Management of hepatitis C virus-related mixed cryoglobulinemia.
Iannuzzella F; Vaglio A; Garini G
Am J Med; 2010 May; 123(5):400-8. PubMed ID: 20399313
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantation.
Abrahamian GA; Cosimi AB; Farrell ML; Schoenfeld DA; Chung RT; Pascual M
Liver Transpl; 2000 Mar; 6(2):185-90. PubMed ID: 10719018
[TBL] [Abstract][Full Text] [Related]
20. Mixed cryoglobulinemia and hepatitis C virus infection.
Lunel F; Musset L
Minerva Med; 2001 Feb; 92(1):35-42. PubMed ID: 11317137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
